VPAC1 Targeted 64 Cu-TP3805 kit preparation and its evaluation
نویسندگان
چکیده
منابع مشابه
VPAC1 receptors for imaging breast cancer: a feasibility study.
UNLABELLED VPAC1 encodes G-protein-coupled receptors expressed on all breast cancer (BC) cells at the onset of the disease, but not on benign lesions. Our extensive preclinical studies have shown that (64)Cu-TP3805 has a high affinity for VPAC1, is stable in vivo, and has the ability to distinguish spontaneously grown malignant BC masses from benign lesions. Our long-term goal is to develop (64...
متن کاملImaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products.
UNLABELLED Despite the great strides made in imaging breast cancer (BC) in humans, the current imaging modalities miss up to 30% of BC, do not distinguish malignant lesions from benign ones, and require histologic examinations for which invasive biopsy must be performed. Annually in the United States, approximately 5.6 million biopsies find benign lesions. More than 50% of human BCs overexpress...
متن کاملPreparation and labeling of HMPAO kit in Iran [Persian]
In recent years, several radiopharmaceuticals have been developed for imaging regional cerebral blood flow (rCBF) such as 75Se labelled PIPSE and MOSE, ²º¹TI labelled DDC and 99mTc labelled HMPAO. HMPAO with two asymmetric carbon atoms (At the 3 and 9 positions), produces d,1 and meso isomers, only one of which is retained in the brain. Rapid intracellular conversion of 99mTc-d,1-HMPAO to...
متن کاملReducing Metal Contamination in Cu-64 production
In the past several years there has been a growing interest in the development of radiopharmaceuticals labeled with metallic radionuclides (1). Of particular interest is the positron emitter Cu (t1⁄2 = 12.7 h) for molecular imaging of small molecules as well as peptides and antibodies (2). This has led us to the recent implementation of a solid target production facility using commercially avai...
متن کاملTechnetium-99m Ceftizoxime Kit Preparation
The aim of this work was to prepare a kit of Tc-ceftizoxime (Tc-CFT), with stability and biological activity preserved, able to identify a septic focus (E. coli) in the experimental infection model in rats. The preparation of the CFT kit involved the use of lyophilized solutions containing the antibiotic ceftizoxime and the sodium dithionite reducing agent (6.0 mg/mL). After lyophilization, the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nuclear Medicine and Biology
سال: 2017
ISSN: 0969-8051
DOI: 10.1016/j.nucmedbio.2017.04.007